Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat
17 Oct 2022 //
GLOBENEWSWIRE
Mereo BioPharma’s Alvelestat Meets Endpoints in ASTRAEUS Trial in AATD
10 May 2022 //
TRIALSITENEWS
Mereo Announces Initiation of Placebo-Controlled Ph 1b/2 Trial with Alvelestat
25 Aug 2020 //
GLOBENEWSWIRE
Celgene says no to Mereo’s cancer drug etigilimab
22 Jun 2019 //
PM LIVE